The use of Camelid antibodies for structural biologyJune 15, 2016
The use of Camelid antibodies has important implications for future development of reagents for diagnosis and therapeutics in diseases involving a group of enzymes called serine proteases.
Antibodies have many applications, in areas ranging from basic molecular biology and biochemistry to clinical medicine. Recently, much interest has been focused on a special group of antibodies from Camelids (camels, dromedaries, llamas). Due to their small size and unique structures, these Camelid antibodies are ideal building blocks for the generation of novel biological drugs, with multiple competitive advantages over other therapeutic molecules. Moreover, Camelid antibodies offer many technical applications in basic biochemistry and structural biology.
Now, a group of Danish, Belgian, and Chinese researchers have used the Camelid antibody technology to explore basic principles of catalysis and inhibition of a group of enzymes called serine proteases, using X-ray crystal structure analysis. Serine proteases catalyse important processes in blood coagulation, fibrinolysis, tissue remodeling, and other physiological functions.
The research team has developed Camelid antibodies against serine proteases, thereby allowing a structural characterization of a long standing problem concerning whether a certain peptide segment will behave as an inhibitor or a substrate for a serine protease. The results also have important implications for future development of reagents for diagnosis and therapeutics in diseases involving serine proteases.
The results have been obtained in a collaboration between researchers from Aarhus (Denmark), Leuven and Brussels (Belgium) and Hong Kong (China). In particular, Serge Muyldermans, Vrijes Universiteit Brussels, who originally pioneered the development of the Camelid antibody technology, has contributed with his expertise. Tobias-Kromann-Hansen, as part of his Ph.D.-study, spent four months in his laboratory. Tobias Kromann-Hansen is currently developing these studies further as a Carlsberg Postdoctoral Research Fellow at the University of California San Diego, USA. The results are being published in the Journal of Biological Chemistry. The publication is one of the achievements of the Danish-Chinese Centre for Proteases and Cancer, headed by Peter A. Andreasen.
For further information, please contact
Professor, dr. scient. Peter Andreasen
Department of Molecular Biology and Genetics
Aarhus University, Denmark
email@example.com - Mobile: +45 23492837
Related Antibodies Articles:
After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first natural human antibodies that can neutralize and protect animals against all three major disease-causing ebolaviruses.
Researchers from the University of Maryland and Rockefeller University have refined a method to modify an antibody's sugar group structure, which plays a large role in determining an antibody's ability to activate the immune response.
Antibodies are able to activate human nerve cells within milliseconds and hence modify their function -- that is the surprising conclusion of a study carried out at Human Biology at the Technical University of Munich (TUM).
Researchers at the University of California, Riverside have camels and llamas to thank for their development of a new cancer treatment that is highly selective in blocking the action of faulty matrix metalloproteinases (MMPs).
Researchers have identified neutralizing antibodies against Zika virus from an infected patient that fully protected mice from infection, adding to the current arsenal of antibodies in development for much needed antiviral therapies and vaccines.
Spinal cord injury (SCI) causes long-lasting damage in the spinal cord that leads to paraparesis, paraplegia, quadriplegia and other lifetime disabilities.
During HIV infection, the virus mutates too rapidly for the immune system to combat, but some people produce antibodies that can recognize the virus even two years after infection.
Emory scientists probe activated B cells, important for forming immune memory, during flu vaccination and infection and Ebola infection in humans.
Antibodies that specifically protect against Zika infection have been identified in mice, report Washington University School of Medicine in St.
Scientists at Washington University School of Medicine in St. Louis have identified antibodies capable of protecting against Zika virus infection, a significant step toward developing a vaccine, better diagnostic tests and possibly new antibody-based therapies.
Related Antibodies Reading:
Antibodies A Laboratory Manual, Second edition
by Edward A. Greenfield (Editor)
It has been 25 years since the now-classic Antibodies by Ed Harlow and David Lane appeared. While some things remain the same, many have changed. This second edition of Antibodies, edited by Edward A. Greenfield of the Dana-Farber Cancer Institute builds on the core strengths of the first edition, presenting clear and authoritative protocols with extensive background information and troubleshooting advice. The original introductory chapters have been recast and updated to take into account our current understanding of the immune system. The critical chapters on generating monoclonal... View Details
by Antoine Dagata (Author)
This monumental collection of d’Agata’s controversial work is a cult classic and companion to one of the most talked-about photography exhibitions of the past decade, available now for the first time in English. Containing striking images of people living on the fringes of society, Antibodies is a challenging and captivating collection from one of the most renowned photographers working today. Antoine d’Agata has traveled the world’s darkest corners collecting images of prostitutes, addicts, war-torn communities, and the homeless. A nomad himself, d’Agata tackles subjects often left... View Details
Antibodies: A Laboratory Manual
by Ed Harlow (Author), David P Lane (Author)
ince its publication in 1988, Antibodies: A Laboratory Manual, by Harlow and Lane, has become a classic, an essential resource for molecular biology, immunology, and cell culture labs. In order to keep the book in print, Cold Spring Harbor Laboratory Press eventually produced the paperback edition currently available for sale.
Now, after 25 years, a second edition is being published in September 2013. Revised, extended and updated by Edward Greenfield of the Dana-Farber Cancer Center, the material has been recast with extensive new information and new chapters have been added. The new... View Details
Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer
by Kenneth J. Olivier Jr. (Editor), Sara A. Hurvitz (Editor)
Providing practical and proven solutions for antibody-drug conjugate (ADC) drug discovery success in oncology, this book helps readers improve the drug safety and therapeutic efficacy of ADCs to kill targeted tumor cells.
• Discusses the basics, drug delivery strategies, pharmacology and toxicology, and regulatory approval strategies
• Covers the conduct and design of oncology clinical trials and the use of ADCs for tumor imaging
• Includes case studies of ADCs in oncology drug development
• Features contributions from highly-regarded experts on the... View Details
Monoclonal Antibodies: Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product
by Steven Shire (Author)
Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use... View Details
Process Scale Purification of Antibodies
by Uwe Gottschalk (Editor)
Promoting a continued and much-needed renaissance in biopharmaceutical manufacturing, this book covers the different strategies and assembles top-tier technology experts to address the challenges of antibody purification.
• Updates existing topics and adds new ones that include purification of antibodies produced in novel production systems, novel separation technologies, novel antibody formats and alternative scaffolds, and strategies for ton-scale manufacturing
• Presents new and updated discussions of different purification technologies, focusing on how they... View Details
Process Scale Purification of Antibodies
by Uwe Gottschalk (Editor)
Traditional column chromatography dominates current purification technology, and many of the productivity gains that have been achieved have relied on upscaling such devices. However, this comes with a cost penalty and the pharmaceutical industry has reached the point at which further upscaling becomes economically unsupportable. This book offers a broad-based reassessment of old and new purification methods, incorporating an analysis of innovative new trends in purification. The book has wide coverage of different antibody purification strategies and brings together top-tier experts to... View Details
Monoclonal Antibodies: Methods and Protocols (Methods in Molecular Biology)
by Vincent Ossipow (Editor), Nicolas Fischer (Editor)
Monoclonal Antibodies: Methods and Protocols, Second Edition expands upon the previous edition with current, detailed modern approaches to isolate and characterize monoclonal antibodies against carefully selected epitopes. This edition includes new chapters covering the key steps to generate high quality monoclonals via different methods, from antigen generation to epitope mapping and quality control of the purified IgG. Chapters are divided into four parts corresponding to four distinct objectives. Part I covers monoclonal antibody generation, Part II deals with monoclonal... View Details
Antibody Engineering: Methods and Protocols, Second Edition (Methods in Molecular Biology)
by Patrick Chames (Editor)
More than ever, antibodies are being recognized as a major drug modality in a variety of diseases, including cancer, autoimmune diseases, infectious diseases, or even neurodegenerative disorders. Over 30 therapeutic antibodies have been approved and novel molecules are entering clinical trials at an average rate of 50 per year and that is predicted to continue well into the future. Notwithstanding the many achievements already made in the field, there is still a lot of room for improvements for these molecules in terms of activity, and a plethora of approaches have been attempted to... View Details
Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area in the Pharmaceutical Industry (Woodhead Publishing Series in Biomedicine)
by William R Strohl (Author), Lila M Strohl (Author)
The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of engineering monoclonal antibodies and analyses the effect that various genetic engineering approaches will have on future candidates. Chapters in the first part of the book provide an introduction to monoclonal antibodies, their discovery and development and the fundamental technologies used in... View Details